Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

Pappas Capital: 1 round · Fireround

Breye Therapeutics ApS[ PART ]

A clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases

Series A$76.8M2026-09-292

Company	Round	Amount	Announced	Role
Breye Therapeutics ApS A clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases	Series A Verified against 2 sources	$76.8M	2026-09-29	[ PART ]